Parker Waichman LLP Headlines by Topic
PML
Rituxan - PML Link Could Spark FDA Action
Jun 1, 2009
| Parker Waichman LLP
U.S. health regulators are taking a look at the lymphoma drug Rituxan because of its possible association with progressive multifocal...
Raptiva Gets Black Box Warning for PML, Other Opportunistic Infections
Oct 17, 2008
| Parker Waichman LLP
The labeling of the psoriasis drug Raptiva will now bear a new black box warning about its association with the deadly brain disease...
Raptiva Added to List of Drugs Linked to Deadly Brain Disease
Oct 6, 2008
| Parker Waichman LLPp
Raptiva, Genentech Inc’s psoriasis drug, may be linked to a deadly brain disease called progressive multifocal leukoencephalopathy, or...
Biotech firms' drug is linked to deaths
Dec 19, 2006
| Los Angeles Times
The bestselling medicine for two of the country's biggest biotech drug companies has been further linked to a rare and deadly brain infection, U.S....
Biogen, Genentech issue warning for Rituxan
Dec 19, 2006
| www.cbsmarketwatch.com
Biogen Idec and Genentech have issued a warning to healthcare providers for their oncology drug Rituxan, advising them that the drug has been linked...
Rituxan (rituxamab) Linked to Two Deaths in Lupus Patients
Dec 19, 2006
| www.medpagetodaycom
Two patients treated with the immune modulator Rituxan (rituximab) for systemic lupus erythmatosus (SLE) have died of progressive multifocal...
Off-Label Use of Rituxan Linked to Fatal Leukoencephalopathy
Dec 19, 2006
| www.medscape.com
The US Food and Drug Administration (FDA) is warning healthcare professionals regarding the risk for progressive multifocal leukoencephalopathy (PML)...
Rituxan warning issued by FDA
Dec 19, 2006
| North County Times
Patients treated with Rituxan may be at risk from a rare, fatal brain infection, the U.S. Food and Drug Administration warned Monday. The FDA said...
FDA ALERT
Dec 18, 2006
| www.fda.gov
This Alert highlights important emerging safety information about Rituxan. Two patients have died after being treated with Rituxan for systemic lupus...
Life-threatening Brain Infection in Patients with Systemic Lupus Erythematosus
Dec 18, 2006
| www.fda.gov
FDA has received reports of the death of two patients who were treated with Rituxan for systemic lupus erythematosus (SLE). Both patients...
